SCHEMBL6424784

SCHEMBL6424784

Cc1c([C@](C)(C(=O)O)C2CCC2)c2cc(O)c(F)cc2n1C(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.36
TSHR P16473 1/20 0.35
HPGD P15428 1/20 0.34
MGLL Q99685 3/20 0.34
RORC P51449 1/20 0.33
FPR2 P25090 1/20 0.32
PROKR1 Q8TCW9 1/20 0.32
AKR1C3 P42330 2/20 0.32
AKR1C2 P52895 2/20 0.32
PGR P06401 2/20 0.32
FAAH O00519 1/20 0.32
KDM2B Q8NHM5 1/20 0.31
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424976 0.98 HSD11B1 (0.36) HSD11B1TSHRHPGDMGLLRORC
SCHEMBL6453005 0.95 PDE2A (0.35) MGLLRORCAKR1C3AKR1C2FAAH
SCHEMBL6464934 0.93 PDE2A (0.35) HSD11B1MGLLRORCAKR1C3AKR1C2
SCHEMBL6425630 0.91 AKR1C3 (0.41) MGLLAKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6425919 0.90 HSD11B1 (0.35) HSD11B1MGLLAKR1C3AKR1C2PGR
SCHEMBL6423924 0.89 AKR1C3 (0.41) MGLLAKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6423432 0.89 HSD11B1 (0.37) HSD11B1MGLLKDM4EMAPT
SCHEMBL6423997 0.88 HSD11B1 (0.35) HSD11B1MGLLAKR1C3AKR1C2PGR
SCHEMBL6423665 0.87 ALDH1A1 (0.37) HSD11B1MGLLAKR1C3AKR1C2KDM2B
SCHEMBL6423630 0.86 AKR1C3 (0.37) HSD11B1MGLLAKR1C3AKR1C2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 HSD11B1 1120/4885TSHR 3525/4885HPGD 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.